Close the Cancer Research funding gap


Regular readers of the blog will know about my calls to allow the drug Abiraterone to be funded on the NHS. Currently, the body making the decision, NICE (National Institute for Clinical. Excellence), is saying no because they say it would cost too much. More expensive drugs have been approved, but helped less people. You have the crazy situation that the drug is being turned down for use because it is effective.

Now, a BBC study has uncovered that 93% of money spent on Cancer Research is spent in the South.  

I accept that the money should be spent where it is most effective, but are policy makers honestly arguing that 93% of the best work is happening in the south? If they are, then I don't believe them.

 

 

Share this post on social media:

Sign in with Facebook, Twitter or Email.